Skip to main content

Articles

Page 71 of 94

  1. Authors: Béatrice Jacquelin, Véronique Mayau, Brice Targat, Anne-Sophie Liovat, Désirée Kunkel, Gaël Petitjean, Marie-Agnès Dillies, Pierre Roques, Cécile Butor, Luis D Giavedoni, Pierre Lebon, Françoise Barré-Sinoussi, Arndt Benecke and Michaela C Müller-Trutwin
    Citation: Retrovirology 2009 6(Suppl 2):I23

    This article is part of a Supplement: Volume 6 Supplement 2

  2. Authors: Marc Sitbon, Hiroyuki Abe, Valérie Courgnaud, Donatella Giovannini, Felix Kim, Madakasira Lavanya, Nicolas Manel, Jawida Touhami, Wiliam M Switzer, Pierre Castelnau, Emmanuelle Lagrue, Lydie Nadal-Desbarats, Karine de Guillen, Christian Roumestand and Jean-Luc Battini
    Citation: Retrovirology 2009 6(Suppl 2):I20

    This article is part of a Supplement: Volume 6 Supplement 2

  3. Authors: Neil Berry, Atze Das, Mark Page, Hannah Tudor, Mark Robinson, Ruby Quartey-Papafio, William Elsley, Deborah Ferguson, Bo Li, Wendy Kleibeuker, Bep Klaver, Maria Manoussaka, Richard Stebbings, Martin Cranage, Ben Berkhout and Neil Almond
    Citation: Retrovirology 2009 6(Suppl 2):P13

    This article is part of a Supplement: Volume 6 Supplement 2

  4. Contamination of vertebrate cell lines with animal retroviruses has been documented repeatedly before. Although such viral contaminants can be easily identified with high sensitivity by PCR, it is impossible t...

    Authors: Alexander Stang, Elisabeth Petrasch-Parwez, Sabine Brandt, Rolf Dermietzel, Helmut E Meyer, Kai Stühler, Sven-T Liffers, Klaus Überla and Thomas Grunwald
    Citation: Retrovirology 2009 6:86
  5. Primary-HIV-1-infection in newborns that occurs under antiretroviral prophylaxis that is a high risk of drug-resistance acquisition. We examine the frequency and the mechanisms of resistance acquisition at the...

    Authors: Constance Delaugerre, Marie-Laure Chaix, Stephane Blanche, Josiane Warszawski, Dorine Cornet, Catherine Dollfus, Veronique Schneider, Marianne Burgard, Albert Faye, Laurent Mandelbrot, Roland Tubiana and Christine Rouzioux
    Citation: Retrovirology 2009 6:85
  6. Most retroviruses enter their host cells by fusing the viral envelope with the plasma membrane. Although the protein machinery promoting fusion has been characterized extensively, the dynamics of the process a...

    Authors: Peter Koch, Marko Lampe, William J Godinez, Barbara Müller, Karl Rohr, Hans-Georg Kräusslich and Maik J Lehmann
    Citation: Retrovirology 2009 6:84
  7. Human T-cell leukemia virus type 1 (HTLV-1) is a causative agent of adult T-cell leukemia (ATL), whereas its relative HTLV-2 is not associated with any malignancies including ATL. HTLV-1 Tax1 transformed a T-c...

    Authors: Toshiyuki Shoji, Masaya Higuchi, Rie Kondo, Masahiko Takahashi, Masayasu Oie, Yuetsu Tanaka, Yutaka Aoyagi and Masahiro Fujii
    Citation: Retrovirology 2009 6:83
  8. The palindromic sequence motifs (CANNTG) known as E boxes are considered as binding sites for the basic helix-loop-helix (bHLH) class of DNA-binding proteins. Their presence has been reported in the long termi...

    Authors: Jean-Michel Terme, Sébastien Calvignac, Madeleine Duc Dodon, Louis Gazzolo and Albert Jordan
    Citation: Retrovirology 2009 6:81
  9. The Human Immunodeficiency virus type 1 (HIV-1) Vpu protein enhances virus release from infected cells and induces proteasomal degradation of CD4. Recent work identified BST-2/CD317 as a host factor that inhib...

    Authors: Amy J Andrew, Eri Miyagi, Sandra Kao and Klaus Strebel
    Citation: Retrovirology 2009 6:80
  10. Therapeutic retroviral vector integration near the oncogene LMO2 is thought to be a cause of leukemia in X-SCID gene therapy trials. However, no published studies have evaluated the frequency of vector integratio...

    Authors: Koichiro Yamada, Tomonori Tsukahara, Kazuhisa Yoshino, Katsuhiko Kojima, Hideyuki Agawa, Yuki Yamashita, Yuji Amano, Mariko Hatta, Yasunori Matsuzaki, Naoki Kurotori, Keiko Wakui, Yoshimitsu Fukushima, Ryosuke Osada, Tanri Shiozawa, Kazuo Sakashita, Kenichi Koike…
    Citation: Retrovirology 2009 6:79
  11. The development of novel techniques and systems to study human infectious diseases in both an in vitro and in vivo settings is always in high demand. Ideally, small animal models are the most efficient method of ...

    Authors: Rachel Van Duyne, Caitlin Pedati, Irene Guendel, Lawrence Carpio, Kylene Kehn-Hall, Mohammed Saifuddin and Fatah Kashanchi
    Citation: Retrovirology 2009 6:76
  12. The human immunodeficiency virus type 1 (HIV-1) Tat protein is a major viral transactivator required for HIV-1 replication. In the nucleus Tat greatly stimulates the synthesis of full-length transcripts from t...

    Authors: Nicolas Charnay, Roland Ivanyi-Nagy, Ricardo Soto-Rifo, Théophile Ohlmann, Marcelo López-Lastra and Jean-Luc Darlix
    Citation: Retrovirology 2009 6:74
  13. Human T-cell leukemia virus type 1 (HTLV-1) causes adult T -cell leukemia (ATL) but the expression of HTLV-1 is strongly suppressed in the peripheral blood of infected people. However, such suppression, which ...

    Authors: Shiwen Jiang, Takefumi Inada, Masakazu Tanaka, Rika A Furuta, Koh Shingu and Jun-ichi Fujisawa
    Citation: Retrovirology 2009 6:73
  14. Mounting evidence indicates that HLA-mediated HIV evolution follows highly stereotypic pathways that result in HLA-associated footprints in HIV at the population level. However, it is not known whether charact...

    Authors: Santiago Avila-Rios, Christopher E Ormsby, Jonathan M Carlson, Humberto Valenzuela-Ponce, Juan Blanco-Heredia, Daniela Garrido-Rodriguez, Claudia Garcia-Morales, David Heckerman, Zabrina L Brumme, Simon Mallal, Mina John, Enrique Espinosa and Gustavo Reyes-Teran
    Citation: Retrovirology 2009 6:72
  15. Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL) and is also associated with a variety of lymphocyte-mediated diseases. The HTLV-1 basic leucine zipper (HBZ) gene, found to ...

    Authors: Masao Matsuoka and Patrick L Green
    Citation: Retrovirology 2009 6:71
  16. Human immunodeficiency virus type 1 (HIV-1) productively infects only humans and chimpanzees but not cynomolgus or rhesus monkeys while simian immunodeficiency virus isolated from macaque (SIVmac) readily esta...

    Authors: Ayumu Kuroishi, Akatsuki Saito, Yasuhiro Shingai, Tatsuo Shioda, Masako Nomaguchi, Akio Adachi, Hirofumi Akari and Emi E Nakayama
    Citation: Retrovirology 2009 6:70
  17. Authors: Jose Henrique Pilotto, Beatriz Grinsztejn, Valdilea Veloso, Jose Carlos Couto-Fernandez, Adriana Rodrigues-Pedro, Carlos Augusto Velasco-de-Castro, Jorge Eurico Ribeiro, Ruth Khalili, Sandra Muri, Ronaldo Ismerio, Judith Courrier and Mariza G Morgado
    Citation: Retrovirology 2009 6(Suppl 1):O14

    This article is part of a Supplement: Volume 6 Supplement 1

  18. Authors: Boubacar Nacro, Yaya Diasso, Emmanuelle Zoure, Potiendi Serge Diabouga, Philippe Van de Perre, Aly Drabo, Adama Ouiminga, François Rouet, Dramane Kania, Souleymane Yameogo, Alain Hien, Hervé Hien and Philippe Msellati
    Citation: Retrovirology 2009 6(Suppl 1):P12

    This article is part of a Supplement: Volume 6 Supplement 1

  19. Authors: Woottichai Khamduang, Catherine Gaudy-Graffin, Alain Moreau, Nicole Ngo-Giang-Huong, Gonzague Jourdain, Marc Lallemant, Surachai Pipatnakulchai, Chaiwat Putiyanun, Sura Kunkongkapan, Pornpun Wannarit, Surat Sirinontakan, Wanna Ardong, Wasna Sirirungsi and Alain Goudeau
    Citation: Retrovirology 2009 6(Suppl 1):O9

    This article is part of a Supplement: Volume 6 Supplement 1

  20. Authors: Suzie Thenin, Tanawan Samleerat, Gonzague Jourdain, Nicole Ngo-Giang-Huong, Alain Moreau, Pranee Leechanachai, Marc Lallemand, Françis Barin and Martine Braibant
    Citation: Retrovirology 2009 6(Suppl 1):P5

    This article is part of a Supplement: Volume 6 Supplement 1

Annual Journal Metrics

  • 2022 Citation Impact
    3.3 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.004 - SNIP (Source Normalized Impact per Paper)
    0.892 - SJR (SCImago Journal Rank)

    2023 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    83 days submission to accept (Median)

    2023 Usage 
    932,795 downloads
    667 Altmetric mentions